nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Benzocaine—SCN11A—melanoma	0.0537	0.208	CrCbGaD
Sulfacetamide—Lupus erythematosus—Docetaxel—melanoma	0.0506	0.0682	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0362	0.0488	CcSEcCtD
Sulfacetamide—Procainamide—SCN11A—melanoma	0.035	0.136	CrCbGaD
Sulfacetamide—Systemic lupus erythematosus—Docetaxel—melanoma	0.034	0.0459	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0307	0.0414	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Dactinomycin—melanoma	0.0294	0.0396	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Temozolomide—melanoma	0.0266	0.0358	CcSEcCtD
Sulfacetamide—Erythema multiforme—Vemurafenib—melanoma	0.0263	0.0355	CcSEcCtD
Sulfacetamide—Erythema—Vemurafenib—melanoma	0.0242	0.0327	CcSEcCtD
Sulfacetamide—Gliclazide—VEGFA—melanoma	0.0228	0.0885	CrCbGaD
Sulfacetamide—Chlorpropamide—SLC15A2—melanoma	0.0222	0.0859	CrCbGaD
Sulfacetamide—Tolbutamide—SLC15A2—melanoma	0.0216	0.0838	CrCbGaD
Sulfacetamide—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.0205	0.0276	CcSEcCtD
Sulfacetamide—Benzocaine—SCN10A—melanoma	0.0202	0.0784	CrCbGaD
Sulfacetamide—Infection—Vemurafenib—melanoma	0.0196	0.0265	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Temozolomide—melanoma	0.0185	0.025	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.0174	0.0234	CcSEcCtD
Sulfacetamide—Agranulocytosis—Dactinomycin—melanoma	0.0164	0.022	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0157	0.0212	CcSEcCtD
Sulfacetamide—Erythema multiforme—Dactinomycin—melanoma	0.0149	0.02	CcSEcCtD
Sulfacetamide—Erythema—Bleomycin—melanoma	0.0147	0.0198	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vemurafenib—melanoma	0.0146	0.0196	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Docetaxel—melanoma	0.0143	0.0193	CcSEcCtD
Sulfacetamide—Pruritus—Vemurafenib—melanoma	0.014	0.0189	CcSEcCtD
Sulfacetamide—Erythema—Dactinomycin—melanoma	0.0137	0.0185	CcSEcCtD
Sulfacetamide—Erythema multiforme—Temozolomide—melanoma	0.0135	0.0181	CcSEcCtD
Sulfacetamide—Procainamide—SCN10A—melanoma	0.0132	0.0511	CrCbGaD
Sulfacetamide—Erythema—Carmustine—melanoma	0.0128	0.0173	CcSEcCtD
Sulfacetamide—Erythema—Temozolomide—melanoma	0.0124	0.0167	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.0123	0.0166	CcSEcCtD
Sulfacetamide—Oedema—Bleomycin—melanoma	0.012	0.0161	CcSEcCtD
Sulfacetamide—Infection—Bleomycin—melanoma	0.0119	0.016	CcSEcCtD
Sulfacetamide—Oedema—Dactinomycin—melanoma	0.0112	0.0151	CcSEcCtD
Sulfacetamide—Infection—Dactinomycin—melanoma	0.0111	0.015	CcSEcCtD
Sulfacetamide—Oedema—Carmustine—melanoma	0.0105	0.0141	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.0104	0.0141	CcSEcCtD
Sulfacetamide—Infection—Carmustine—melanoma	0.0104	0.014	CcSEcCtD
Sulfacetamide—Pain—Bleomycin—melanoma	0.0102	0.0138	CcSEcCtD
Sulfacetamide—Oedema—Temozolomide—melanoma	0.0101	0.0136	CcSEcCtD
Sulfacetamide—Infection—Temozolomide—melanoma	0.01	0.0135	CcSEcCtD
Sulfacetamide—Agranulocytosis—Docetaxel—melanoma	0.00983	0.0133	CcSEcCtD
Sulfacetamide—Pain—Dactinomycin—melanoma	0.00956	0.0129	CcSEcCtD
Sulfacetamide—Sulfamethazine—ALB—melanoma	0.00929	0.036	CrCbGaD
Sulfacetamide—Sulfamerazine—ALB—melanoma	0.00908	0.0352	CrCbGaD
Sulfacetamide—Erythema multiforme—Docetaxel—melanoma	0.00895	0.0121	CcSEcCtD
Sulfacetamide—Pain—Carmustine—melanoma	0.00894	0.0121	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bleomycin—melanoma	0.00883	0.0119	CcSEcCtD
Sulfacetamide—Pain—Temozolomide—melanoma	0.00864	0.0116	CcSEcCtD
Sulfacetamide—Pruritus—Bleomycin—melanoma	0.00848	0.0114	CcSEcCtD
Sulfacetamide—Erythema—Docetaxel—melanoma	0.00824	0.0111	CcSEcCtD
Sulfacetamide—Hypersensitivity—Dactinomycin—melanoma	0.00823	0.0111	CcSEcCtD
Sulfacetamide—Hypersensitivity—Carmustine—melanoma	0.00771	0.0104	CcSEcCtD
Sulfacetamide—Hypersensitivity—Temozolomide—melanoma	0.00745	0.01	CcSEcCtD
Sulfacetamide—Pruritus—Temozolomide—melanoma	0.00715	0.00964	CcSEcCtD
Sulfacetamide—Sulfamethizole—ALB—melanoma	0.00704	0.0273	CrCbGaD
Sulfacetamide—Oedema—Docetaxel—melanoma	0.00672	0.00906	CcSEcCtD
Sulfacetamide—Infection—Docetaxel—melanoma	0.00668	0.009	CcSEcCtD
Sulfacetamide—Gliclazide—ALB—melanoma	0.00614	0.0238	CrCbGaD
Sulfacetamide—Pain—Docetaxel—melanoma	0.00575	0.00775	CcSEcCtD
Sulfacetamide—Acetaminophen—PTGS2—melanoma	0.00531	0.0206	CrCbGaD
Sulfacetamide—Hypersensitivity—Docetaxel—melanoma	0.00495	0.00667	CcSEcCtD
Sulfacetamide—Pruritus—Docetaxel—melanoma	0.00476	0.00641	CcSEcCtD
Sulfacetamide—Chlorpropamide—ABCB1—melanoma	0.00455	0.0177	CrCbGaD
Sulfacetamide—Acetaminophen—ABCB1—melanoma	0.00451	0.0175	CrCbGaD
Sulfacetamide—Benzocaine—ABCB1—melanoma	0.00444	0.0172	CrCbGaD
Sulfacetamide—Sulfamethoxazole—ALB—melanoma	0.00395	0.0153	CrCbGaD
Sulfacetamide—Probenecid—ALB—melanoma	0.00394	0.0153	CrCbGaD
Sulfacetamide—Probenecid—ABCB1—melanoma	0.00376	0.0146	CrCbGaD
Sulfacetamide—Aminohippurate—ABCB1—melanoma	0.00371	0.0144	CrCbGaD
Sulfacetamide—Dapsone—PTGS2—melanoma	0.00347	0.0135	CrCbGaD
